Smith Nephew Partners With SI BONE To Expand Trauma Portfolio

Advancing Pelvic Fracture Treatment: How the iFuse TORQ Portfolio Outperforms Traditional Fixation Methods
Recent advancements in orthopedic surgery have introduced more effective alternatives to the traditional cannulated screws long used for pelvic fracture fixation. On February 23, 2026, Smith & Nephew announced a strategic distribution agreement with SI-BONE to integrate the iFuse TORQ portfolio into its trauma offerings. This partnership addresses a critical need for superior stabilization in high-frequency, high-impact pelvic procedures, particularly for patients with compromised bone density.

Enhanced Stability Through 3D-Printed Technology
The primary differentiation between the iFuse TORQ system and conventional screws lies in its design and material science. Unlike traditional smooth-surfaced screws, iFuse TORQ implants feature a proprietary 3D-printed porous lattice surface. This architecture is engineered to mimic the structure of natural cancellous bone, facilitating osseointegration—the functional connection between the living bone and the implant.

Clinical data indicates that this technology provides significantly higher rotational resistance than standard screws, which is essential for stabilizing the complex anatomy of the sacroiliac joint. By promoting bone ingrowth and through-growth, these implants offer a more durable, long-term solution for joint fusion and fracture repair.

Specialized Solutions for Complex Anatomy
A key component of the new portfolio is the iFuse TORQ TNT (Through ’N Through) system. This device is specifically designed to navigate the anatomical challenges of the sacrum and ilium. It has received the FDA’s Breakthrough Device Designation, a status reserved for technologies that provide more effective treatment of life-threatening or irreversibly debilitating conditions compared to existing standards of care.

The iFuse TORQ TNT addresses the limitations of traditional fixation by providing a "through and through" design that secures the entire pelvic ring. This is particularly beneficial for treating fragility fractures in elderly patients or those with osteopenia, where traditional hardware often fails to maintain adequate purchase in low-density bone.

Economic and Clinical Advantages for Hospitals
Beyond clinical performance, the adoption of iFuse TORQ technology offers logistical and financial advantages. The iFuse TORQ TNT system is eligible for the Medicare New Technology Add-on Payment (NTAP), which can provide hospitals with up to $4,136 in additional reimbursement per procedure.

This reimbursement support, combined with the proven clinical evidence from over 140,000 procedures and 180 peer-reviewed publications, positions the iFuse TORQ portfolio as a more sustainable and effective choice for modern trauma centers. By expanding access to these differentiated solutions, Smith & Nephew aims to improve patient recovery times and surgical outcomes in the evolving landscape of pelvic trauma care.

www.smith-nephew.com